Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

33

Revenue 2017

Humalog

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Humalog was produced by Lilly.

Lilly feels effects of Cymbalta competition

Lilly feels effects of Cymbalta competition Offsetting the decline, lung cancer therapy Alimta (pemetrexed) rose 6 per cent to $726m, while insulin products Humalog and Humulin both performed well, respectively up 19 per cent to $734m and

Biocon and Advaxis partner on cancer immunotherapy

Biocon and Advaxis partner on cancer immunotherapy This includes a collaboration with Mylan to develop biosimilar versions of three major insulin products: Sanofi's Lantus, Lilly's Humalog and Novo Nordisk's Novolog.

Lilly invests $700m in insulin manufacturing

Lilly invests $700m in insulin manufacturing The pharma company, which manufactures the Humalog family of insulins, will expand operations in Puerto Rico, France and China, as well as its hometown of Indianapolis in the US.

EASD 2013: Sanofi prepared for biosimilar threat to Lantus

EASD 2013: Sanofi prepared for biosimilar threat to Lantus Lantus as well as Lilly's insulin Humalog and Novo Nordisk's Novolog.

Lilly/ Boehringer's Lantus biosimilar accepted for EMA review

Lilly/ Boehringer's Lantus biosimilar accepted for EMA review One of those firms is Mylan, which is collaborating with Biocon to develop and commercialise the Indian biotech firm's versions of Lantus, Lilly's Humalog and Novo Nordisk's NovoLog.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...